Products - Chronic kidney disease | Topic | NICE

Showing 5 products

Date | Title

Product type: GuidanceRemove ‘Product type: Guidance’ filter
Status: In developmentRemove ‘Status: In development’ filter

Canagliflozin for treating chronic kidney disease in people with type 2 diabetes [ID1653]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Daprodustat for treating anaemia in people with chronic kidney disease [ID3987]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Obinutuzumab with mycophenolate mofetil for treating lupus nephritis [ID6420]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
12 February 2026
Pegcetacoplan for treating primary complement 3 glomerulopathy and primary immune-complex membranoproliferative glomerulonephritis in people 12 years and over [ID6489]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
18 June 2026
Sirolimus-eluting collagen implant for creating vascular access for haemodialysis in end-stage kidney disease [TSID9147]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC